Mazza, Mario Gennaro

Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors

Mazza, M. G., De Lorenzo, R., Conte, C., Poletti, S., Vai, B., Bollettini, I., Melloni, E. M. T., Furlan, R., Ciceri, F., Rovere-Querini, P., et al. (2020) · Brain, Behavior, and Immunity

COVID-19 and Mental HealthLong-Term Effects of COVID-19

Cited by 1,804

Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up

Mazza, M. G., Palladini, M., De Lorenzo, R., Magnaghi, C., Poletti, S., Furlan, R., Ciceri, F., Rovere-Querini, P., & Benedetti, F. (2021) · Brain, Behavior, and Immunity

Long-Term Effects of COVID-19COVID-19 and Mental Health

Cited by 513

Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in mood disorders: A meta-analysis

Mazza, M. G., Lucchi, S., Tringali, A. G. M., Rossetti, A., Botti, E. R., & Clerici, M. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry

Inflammatory Biomarkers in Disease PrognosisBipolar Disorder and Treatment

Cited by 326

Neutrophil-lymphocyte ratio, monocyte-lymphocyte ratio and platelet-lymphocyte ratio in non-affective psychosis: A meta-analysis and systematic review

Mazza, M. G., Lucchi, S., Rossetti, A., & Clerici, M. (2020) · The World Journal of Biological Psychiatry

Inflammatory Biomarkers in Disease PrognosisTryptophan and brain disorders

Cited by 191

Residual clinical damage after COVID-19: a retrospective and prospective observational cohort study

De Lorenzo, R., Conte, C., Lanzani, C., Benedetti, F., Roveri, L., Mazza, M. G., Brioni, E., Giacalone, G., Canti, V., Sofia, V., et al. (2020) · PLoS ONE

Long-Term Effects of COVID-19COVID-19 Clinical Research Studies

Cited by 179

Cross-sectional study of neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratios in mood disorders

Mazza, M. G., Tringali, A. G. M., Rossetti, A., Botti, R. E., & Clerici, M. (2019) · General Hospital Psychiatry

Bipolar Disorder and TreatmentTryptophan and brain disorders

Cited by 89

Rapid response to selective serotonin reuptake inhibitors in post-COVID depression

Mazza, M. G., Zanardi, R., Palladini, M., Rovere-Querini, P., & Benedetti, F. (2022) · European Neuropsychopharmacology

Treatment of Major DepressionCOVID-19 and Mental Health

Cited by 75

Higher Baseline Interleukin-1β and TNF-α Hamper Antidepressant Response in Major Depressive Disorder

Benedetti, F., Poletti, S., Vai, B., Mazza, M. G., Lorenzi, C., Brioschi, S., Aggio, V., Branchi, I., Colombo, C., Furlan, R., et al. (2021) · European Neuropsychopharmacology

Tryptophan and brain disordersTreatment of Major Depression

Cited by 62

Can Cytokine Blocking Prevent Depression in COVID-19 Survivors?

Benedetti, F., Mazza, M., Cavalli, G., Ciceri, F., Dagna, L., & Rovere-Querini, P. (2021) · Journal of Neuroimmune Pharmacology

Tryptophan and brain disordersLong-Term Effects of COVID-19

Cited by 55

Antidepressant psychopharmacology: is inflammation a future target?

Benedetti, F., Zanardi, R., & Mazza, M. G. (2022) · International Clinical Psychopharmacology

Tryptophan and brain disordersTreatment of Major Depression

Cited by 45

Higher Interleukin 13 Differentiates Patients with a Positive History of Suicide Attempts in Major Depressive Disorder

Vai, B., Mazza, M. G., Cazzetta, S., Calesella, F., Aggio, V., Lorenzi, C., Zanardi, R., Poletti, S., Colombo, C., & Benedetti, F. (2021) · Journal of Affective Disorders Reports

Tryptophan and brain disordersSuicide and Self-Harm Studies

Cited by 13